قارن الطرق
راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.
| بطارية التقييم الجبهي× | فحص أدنبروك المعرفي× | |
|---|---|---|
| المجال | علم النفس العصبي | علم النفس العصبي |
| العائلة | Process / pipeline | Process / pipeline |
| سنة النشأة | 2000 | 2000 |
| صاحب الطريقة≠ | Bruno Dubois | Padasalai Mathuranath |
| النوع≠ | Clinician-administered neuropsychological battery for frontal lobe function | Clinician-administered comprehensive cognitive examination |
| المصدر التأسيسي≠ | Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626. DOI ↗ | Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620. DOI ↗ |
| الأسماء البديلة≠ | FAB, Frontal Battery | ACE, ACE-R, ACE-III, Addenbrooke Cognitive Examination |
| ذات صلة | 5 | 5 |
| الملخص≠ | The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function. | The Addenbrooke's Cognitive Examination (ACE) is a brief yet comprehensive clinician-administered cognitive battery designed to assess multiple cognitive domains and differentiate between types of dementia. Originally developed by Mathuranath and colleagues at Cambridge University in 2000, the ACE was created to address limitations of single-domain screening tools. The revised version (ACE-R, 2006) and further refined version (ACE-III, 2013) provide updated norms and improved sensitivity. The ACE-R and ACE-III are particularly valuable for distinguishing Alzheimer's disease from frontotemporal dementia. |
| ScholarGateمجموعة البيانات ↗ |
|
|